Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
9.55 CAD | -1.85% | +4.37% | -3.54% |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- This company will be of major interest to investors in search of a high dividend stock.
- Sales forecast by analysts have been recently revised upwards.
- The opinion of analysts covering the stock has improved over the past four months.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- Based on current prices, the company has particularly high valuation levels.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Diversified REITs
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-1.72% | 1.87B | B- | ||
-8.07% | 13.03B | B | ||
-6.72% | 8.28B | A | ||
-3.80% | 6.4B | A | ||
-0.48% | 5.66B | A | ||
-6.90% | 5.69B | A- | ||
+6.42% | 4.77B | C+ | ||
+0.81% | 4.76B | A- | ||
-6.67% | 4.67B | C | ||
+2.42% | 3.89B | C |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- HR.UN Stock
- Ratings H&R Real Estate Investment Trust